We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WYETH EFFEXOR PROMOTIONS DRAW DDMAC WARNING
WYETH EFFEXOR PROMOTIONS DRAW DDMAC WARNING
April 2, 2004
The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) has issued a warning letter to Wyeth Pharmaceuticals for misleading claims about the company’s Effexor antidepressant.